Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

Giuseppe Tarantini; Janarthanan Sathananthan; Tommaso Fabris; Uri Landes; Vinayak N. Bapat; Jaffar M. Khan; Luca Nai Fovino; Syed Zaid; Nicolas M. Van Mieghem; Azeem Latib; Ron Waksman; Ole De Backer; Toby Rogers; Lars Søndergaard; Gilbert H.L. Tang

doi:10.1016/j.jcin.2022.07.035

Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

Giuseppe Tarantini^*, Janarthanan Sathananthan, Tommaso Fabris, Uri Landes, Vinayak N. Bapat, Jaffar M. Khan, Luca Nai Fovino, Syed Zaid, Nicolas M. Van Mieghem, Azeem Latib, Ron Waksman, Ole De Backer, Toby Rogers, Lars Søndergaard, Gilbert H.L. Tang

^*Corresponding author for this work

Research output: Contribution to journal › Review › Research › peer-review

51 Citations (Scopus)

Abstract

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

Original language	English
Journal	JACC: Cardiovascular Interventions
Volume	15
Issue number	18
Pages (from-to)	1777-1793
ISSN	1936-8798
DOIs	https://doi.org/10.1016/j.jcin.2022.07.035
Publication status	Published - 2022

Bibliographical note

Publisher Copyright:
© 2022 American College of Cardiology Foundation

Keywords

redo-TAVR
transcatheter heart valve
valve in valve

Access to Document

10.1016/j.jcin.2022.07.035

Cite this

Tarantini, G., Sathananthan, J., Fabris, T., Landes, U., Bapat, V. N., Khan, J. M., Nai Fovino, L., Zaid, S., Van Mieghem, N. M., Latib, A., Waksman, R., De Backer, O., Rogers, T., Søndergaard, L., & Tang, G. H. L. (2022). Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. JACC: Cardiovascular Interventions, 15(18), 1777-1793. https://doi.org/10.1016/j.jcin.2022.07.035

Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. / Tarantini, Giuseppe; Sathananthan, Janarthanan; Fabris, Tommaso; Landes, Uri; Bapat, Vinayak N.; Khan, Jaffar M.; Nai Fovino, Luca; Zaid, Syed; Van Mieghem, Nicolas M.; Latib, Azeem; Waksman, Ron; De Backer, Ole; Rogers, Toby; Søndergaard, Lars; Tang, Gilbert H.L.

In: JACC: Cardiovascular Interventions, Vol. 15, No. 18, 2022, p. 1777-1793.

Research output: Contribution to journal › Review › Research › peer-review

Tarantini, G, Sathananthan, J, Fabris, T, Landes, U, Bapat, VN, Khan, JM, Nai Fovino, L, Zaid, S, Van Mieghem, NM, Latib, A, Waksman, R, De Backer, O, Rogers, T, Søndergaard, L & Tang, GHL 2022, 'Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves', JACC: Cardiovascular Interventions, vol. 15, no. 18, pp. 1777-1793. https://doi.org/10.1016/j.jcin.2022.07.035

Tarantini, Giuseppe ; Sathananthan, Janarthanan ; Fabris, Tommaso ; Landes, Uri ; Bapat, Vinayak N. ; Khan, Jaffar M. ; Nai Fovino, Luca ; Zaid, Syed ; Van Mieghem, Nicolas M. ; Latib, Azeem ; Waksman, Ron ; De Backer, Ole ; Rogers, Toby ; Søndergaard, Lars ; Tang, Gilbert H.L. / Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. In: JACC: Cardiovascular Interventions. 2022 ; Vol. 15, No. 18. pp. 1777-1793.

@article{fb3a66186c344b3e873aefeea451288c,

title = "Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves",

abstract = "Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.",

keywords = "redo-TAVR, transcatheter heart valve, valve in valve",

author = "Giuseppe Tarantini and Janarthanan Sathananthan and Tommaso Fabris and Uri Landes and Bapat, {Vinayak N.} and Khan, {Jaffar M.} and {Nai Fovino}, Luca and Syed Zaid and {Van Mieghem}, {Nicolas M.} and Azeem Latib and Ron Waksman and {De Backer}, Ole and Toby Rogers and Lars S{\o}ndergaard and Tang, {Gilbert H.L.}",

note = "Publisher Copyright: {\textcopyright} 2022 American College of Cardiology Foundation",

year = "2022",

doi = "10.1016/j.jcin.2022.07.035",

language = "English",

volume = "15",

pages = "1777--1793",

journal = "J A C C: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier",

number = "18",

}

TY - JOUR

T1 - Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

AU - Tarantini, Giuseppe

AU - Sathananthan, Janarthanan

AU - Fabris, Tommaso

AU - Landes, Uri

AU - Bapat, Vinayak N.

AU - Khan, Jaffar M.

AU - Nai Fovino, Luca

AU - Zaid, Syed

AU - Van Mieghem, Nicolas M.

AU - Latib, Azeem

AU - Waksman, Ron

AU - De Backer, Ole

AU - Rogers, Toby

AU - Søndergaard, Lars

AU - Tang, Gilbert H.L.

PY - 2022

Y1 - 2022

N2 - Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

AB - Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

KW - redo-TAVR

KW - transcatheter heart valve

KW - valve in valve

U2 - 10.1016/j.jcin.2022.07.035

DO - 10.1016/j.jcin.2022.07.035

M3 - Review

C2 - 36137681

AN - SCOPUS:85137652922

VL - 15

SP - 1777

EP - 1793

JO - J A C C: Cardiovascular Interventions

JF - J A C C: Cardiovascular Interventions

SN - 1936-8798

IS - 18

ER -